
AstraZeneca | Cafepharma
3 days ago · AstraZeneca’s investigational ATR kinase inhibitor did not improve overall survival when combined with Imfinzi in patients with non-small cell lung cancer during a Phase III …
baxdrostat | Cafepharma
Dec 3, 2025 · AstraZeneca's baxdrostat has hit the mark in another phase 3 trial involving people who struggle to control their blood pressure with current therapies, keeping the would-be …
Imfinzi | Cafepharma
Nov 26, 2025 · The FDA has recently approved AstraZeneca’s Imfinzi (durvalumab) for perioperative use in cisplatin-eligible muscle-invasive bladder cancer (MIBC), based on the …
light chain amyloidosis | Cafepharma
Dec 4, 2025 · Almost four years after penning its first amyloidosis collaboration with Neurimmune, AstraZeneca has returned to pick up a second asset. The latest licensing deal involves NI009, …
Caprelsa | Cafepharma
Aug 23, 2023 · Caprelsa AstraZeneca sells rare cancer drug to Sanofi for up to $300 million Submitted by admin on Mon, 07/27/2015 - 10:00 Read more about AstraZeneca sells rare …
AstraZeneca | Cafepharma Message Boards | Pharma Sales, Device …
Nov 19, 2014 · Anonymous board for AstraZeneca.
Fasenra | Cafepharma
Nov 9, 2025 · AstraZeneca's Fasenra (benralizumab) has recently been approved by the FDA for treating severe asthma in children aged 6 to 11 with the eosinophilic phenotype. A phase III …
Luye Pharma Buys Rights to Seroquel in China and Other …
AstraZeneca has entered into an agreement with Luye Pharma Group, Ltd. (Luye Pharma) for the sale and licence of the rights to Seroquel and Seroquel XR in the UK, China and other …
Airsupra | Cafepharma
Sep 26, 2025 · AstraZeneca is the latest Big Pharma to unveil a digital direct-to-consumer platform offering certain medicines at heavily reduced prices to cash-pay patients. …
July 24 2025 - AstraZeneca drug acquired in Alexion deal succeeds …
Jul 24, 2025 · AstraZeneca drug acquired in Alexion deal succeeds in autoimmune disease trialAstraZeneca boardPharma giant Roche sees income soar in first halfRoche boardNovartis …